Tag Archives: Viral Inactivation Market

The global market for viral inactivation reached USD 550 million in 2021 and is anticipated to expand at a CAGR of 12.5% from 2022 to 2030. Regulatory authorities require viral inactivation testing for investigational new drug (IND) submission, and it is essential for the process development of biologicals including tissue and tissue products, stem cell products, cellular and gene therapy ...